Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
History
Sports
Technology
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/5d/5d/4d/5d5d4dd8-9493-e776-c176-ca1f4ef600a0/mza_6967934515800274240.jpg/600x600bb.jpg
DarshanTalks Podcast
Darshan Kulkarni
305 episodes
1 day ago
For decades, biotech M&A followed a familiar script. Patents drove value. Molecules closed deals. That script is breaking. In today’s precision medicine transactions, the real asset is data. Longitudinal patient records, real-world evidence, and genomic datasets are now central to valuation. But unlike traditional IP, data comes with strings attached. Privacy laws, patient consent, and transfer restrictions can quietly determine whether that data is an asset or a liability. In this episod...
Show more...
Life Sciences
Education,
Society & Culture,
How To,
Science,
Documentary
RSS
All content for DarshanTalks Podcast is the property of Darshan Kulkarni and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
For decades, biotech M&A followed a familiar script. Patents drove value. Molecules closed deals. That script is breaking. In today’s precision medicine transactions, the real asset is data. Longitudinal patient records, real-world evidence, and genomic datasets are now central to valuation. But unlike traditional IP, data comes with strings attached. Privacy laws, patient consent, and transfer restrictions can quietly determine whether that data is an asset or a liability. In this episod...
Show more...
Life Sciences
Education,
Society & Culture,
How To,
Science,
Documentary
Episodes (0/305)
DarshanTalks Podcast
For decades, biotech M&A followed a familiar script. Patents drove value. Molecules closed deals. That script is breaking. In today’s precision medicine transactions, the real asset is data. Longitudinal patient records, real-world evidence, and genomic datasets are now central to valuation. But unlike traditional IP, data comes with strings attached. Privacy laws, patient consent, and transfer restrictions can quietly determine whether that data is an asset or a liability. In this episod...